Dolby Laboratories, Inc.
DLB
$65.27
$1.081.68%
NYSE
| 06/26/2026 | 03/27/2026 | 12/26/2025 | 09/26/2025 | 06/27/2025 | |
|---|---|---|---|---|---|
| Revenue | 305.00M | 395.63M | 346.71M | 307.02M | 315.55M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 305.00M | 395.63M | 346.71M | 307.02M | 315.55M |
| Cost of Revenue | 40.32M | 44.73M | 43.21M | 39.52M | 44.00M |
| Gross Profit | 264.68M | 350.90M | 303.50M | 267.51M | 271.54M |
| SG&A Expenses | 160.66M | 172.12M | 161.80M | 164.24M | 158.47M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 266.72M | 280.50M | 274.08M | 271.22M | 268.45M |
| Operating Income | 38.27M | 115.13M | 72.63M | 35.81M | 47.09M |
| Income Before Tax | 43.80M | 119.70M | 71.60M | 41.67M | 55.52M |
| Income Tax Expenses | 14.59M | 24.25M | 17.92M | -7.99M | 8.97M |
| Earnings from Continuing Operations | 29.21M | 95.45M | 53.68M | 49.65M | 46.54M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -612.00K | -539.00K | -354.00K | -322.00K | -471.00K |
| Net Income | 28.60M | 94.92M | 53.33M | 49.33M | 46.07M |
| EBIT | 38.27M | 115.13M | 72.63M | 35.81M | 47.09M |
| EBITDA | 60.87M | 139.23M | 96.77M | 57.80M | 69.02M |
| EPS Basic | 0.30 | 1.00 | 0.56 | 0.52 | 0.48 |
| Normalized Basic EPS | 0.31 | 0.79 | 0.53 | 0.31 | 0.35 |
| EPS Diluted | 0.30 | 0.99 | 0.55 | 0.51 | 0.48 |
| Normalized Diluted EPS | 0.31 | 0.79 | 0.53 | 0.31 | 0.35 |
| Average Basic Shares Outstanding | 94.24M | 95.22M | 95.47M | 95.63M | 95.90M |
| Average Diluted Shares Outstanding | 94.52M | 95.52M | 96.52M | 96.85M | 96.90M |
| Dividend Per Share | 0.36 | 0.36 | 0.36 | 0.36 | 0.33 |
| Payout Ratio | 118.82% | 36.17% | 64.39% | 64.03% | 68.66% |